المؤلفون: Geurts SME; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands. sandra.geurts@mumc.nl., Ibragimova KIE; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Ding N; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Meegdes M; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Erdkamp F; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, The Netherlands., Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, The Netherlands., van de Winkel L; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands., Peters NAJB; Department of Internal Medicine, Sint Jans Gasthuis Hospital, Weert, Netherlands., van de Wouw AJ; Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands., Maaskant SAJG; Department of Surgery, Máxima Medical Center, Eindhoven, The Netherlands., Teeuwen-Dedroog NJA; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., van Nijnatten TJA; Department of Radiology and Nuclear Medicine, GROW, Maastricht University Medical Center, Maastricht, The Netherlands., de Boer M; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 287-302. Date of Electronic Publication: 2024 Feb 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/mortality , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Receptor, ErbB-2*/metabolism , Registries*, Humans ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Neoplasm Metastasis ; Kaplan-Meier Estimate ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use

المؤلفون: Ibragimova KIE; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Geurts SME; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Laczkó D; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., Meegdes M; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Erdkamp F; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, The Netherlands., Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina hospital, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius hospital, Roermond, The Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek hospital, Helmond, The Netherlands., Peters NAJB; Department of Internal Medicine, St. Jans Gasthuis, Weert, The Netherlands., van de Winkel LMH; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands., van de Wouw AJ; Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands., de Fallois A; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., van Kats MACE; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. Electronic address: vcg.tjan.heijnen@mumc.nl.

المصدر: Clinical breast cancer [Clin Breast Cancer] 2024 Feb; Vol. 24 (2), pp. 103-111. Date of Electronic Publication: 2023 Nov 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology, Humans ; Female ; Trastuzumab ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Receptor, ErbB-2/metabolism ; Progression-Free Survival ; Proportional Hazards Models

المؤلفون: Lammers SWM; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Thurisch H; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Vriens IJH; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Meegdes M; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Engelen SME; Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands., Erdkamp FLG; Department of Internal Medicine, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Centre, Eindhoven, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, The Netherlands., van de Winkel LMH; Department of Internal Medicine, St. Anna Hospital, Geldrop, The Netherlands., Peters NAJB; Department of Internal Medicine, St. Jans Gasthuis, Weert, The Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Heijns JB; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., van de Wouw AJ; Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands., Teeuwen NJA; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Geurts SME; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jan; Vol. 203 (2), pp. 339-349. Date of Electronic Publication: 2023 Oct 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/complications , Breast Neoplasms*/epidemiology , Breast Neoplasms*/metabolism, Humans ; Female ; Prognosis ; Overweight/complications ; Overweight/epidemiology ; Body Mass Index ; Thinness/complications ; Obesity/complications ; Obesity/epidemiology

المؤلفون: Ibragimova KIE; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands., Geurts SME; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands., Meegdes M; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands., Erdkamp F; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, the Netherlands., Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, the Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, the Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, the Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, the Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, the Netherlands., van de Winkel L; Department of Internal Medicine, St Anna Hospital, Geldrop, the Netherlands., Peters NAJB; Department of Internal Medicine, Sint Jans Gasthuis Hospital, Weert, the Netherlands., Teeuwen-Dedroog NJA; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands., Vriens IJH; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands. vcg.tjan.heijnen@mumc.nl.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Apr; Vol. 198 (2), pp. 239-251. Date of Electronic Publication: 2023 Jan 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism, Humans ; Female ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Trastuzumab/therapeutic use ; Disease-Free Survival ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Bos-van den Hoek DW; Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD, Amsterdam, The Netherlands. d.w.bos@amsterdamumc.nl.; Quality of Care Program, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands. d.w.bos@amsterdamumc.nl.; Cancer Center Amsterdam, Amsterdam, The Netherlands. d.w.bos@amsterdamumc.nl., van Laarhoven HWM; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Ali R; Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD, Amsterdam, The Netherlands., Bakker SD; Department of Medical Oncology, Zaans Medical Center, Zaandam, The Netherlands., Goosens A; Department of Oncology, Red Cross Hospital, Beverwijk, The Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands., Pepels MJAE; Department of Oncology, Elkerliek Hospital, Helmond, The Netherlands., Tange D; Dutch Federation of Cancer Patient Organizations (NFK), Utrecht, The Netherlands., de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van de Wouw AJ; Department of Oncology, VieCuri Medical Center, Venlo, The Netherlands., Smets EMA; Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.; Quality of Care Program, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., Henselmans I; Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.; Quality of Care Program, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Feb 23; Vol. 31 (3), pp. 184. Date of Electronic Publication: 2023 Feb 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Education, Distance* , Oncologists*/education , Neoplasms*/drug therapy, Humans ; Decision Making, Shared ; Communication ; Decision Making ; Patient Participation

المؤلفون: Meegdes M; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Geurts SME; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Erdkamp FLG; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, the Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, the Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, the Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, the Netherlands., van de Winkel LMH; Department of Internal Medicine, St Anna Hospital, Geldrop, the Netherlands., Peters NAJB; Department of Internal Medicine, St. Jans Gasthuis, Weert, the Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands., Heijns JB; Department of Internal Medicine, Amphia Hospital Breda, the Netherlands., van de Wouw AJ; Department of Internal Medicine, Viecuri Medical Centre, Venlo, the Netherlands., de Fallois AJO; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., van Kats MACE; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.

المصدر: The Lancet regional health. Europe [Lancet Reg Health Eur] 2023 Jan 06; Vol. 26, pp. 100573. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

المؤلفون: Meegdes M; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Ibragimova KIE; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Lobbezoo DJA; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands., Vriens IJH; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Kooreman LFS; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands., Erdkamp FLG; Department of Internal Medicine, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands., Dercksen MW; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, The Netherlands., van de Winkel LMH; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands., Heijns JB; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., van de Wouw AJ; Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands., Peters NAJB; Department of Internal Medicine, St. Jans Gasthuis, Weert, The Netherlands., Hochstenbach-Waelen A; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands., Smidt ML; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands., Geurts SME; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Apr; Vol. 192 (2), pp. 331-342. Date of Electronic Publication: 2022 Jan 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/epidemiology , Breast Neoplasms*/metabolism , Breast Neoplasms*/therapy, Biomarkers, Tumor/metabolism ; Female ; Hormones ; Humans ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Progesterone/genetics ; Receptors, Progesterone/metabolism ; Registries

المؤلفون: Meegdes M; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Geurts SME; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Erdkamp FLG; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, The Netherlands., van de Winkel LMH; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands., Teeuwen NJA; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., de Boer M; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

المصدر: International journal of cancer [Int J Cancer] 2022 Jan 01; Vol. 150 (1), pp. 124-131. Date of Electronic Publication: 2021 Sep 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*drug therapy , Cyclin-Dependent Kinase 4/*antagonists & inhibitors , Cyclin-Dependent Kinase 6/*antagonists & inhibitors , Protein Kinase Inhibitors/*therapeutic use , Receptor, ErbB-2/*metabolism , Receptors, Estrogen/*metabolism , Receptors, Progesterone/*metabolism, Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/epidemiology ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Netherlands/epidemiology ; Patient Selection ; Prognosis ; Registries/statistics & numerical data ; Retrospective Studies ; Survival Rate

المؤلفون: Ibragimova KIE; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Geurts SME; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Croes S; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Erdkamp F; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, The Netherlands., Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, The Netherlands., Peters NAJB; Department of Internal Medicine, Sint Jans Gasthuis, Weert, The Netherlands., van de Winkel L; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands., Tilli DJP; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Vriens IJH; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., de Boer M; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jul; Vol. 188 (2), pp. 571-581. Date of Electronic Publication: 2021 Mar 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/epidemiology, Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Netherlands/epidemiology ; Receptor, ErbB-2/genetics ; Registries ; Trastuzumab/therapeutic use

المؤلفون: Noteboom EA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. e.a.noteboom@umcutrecht.nl., de Wit NJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands., van Asseldonk IJEM; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Janssen MCAM; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Lam-Wong WY; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Linssen RHPJ; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Pepels MJAE; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Schrama NAWP; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Trompper MEH; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Veldhuizen LM; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Wijtvliet AP; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Zeldenrust EGF; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Hendrikx AM; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., van de Boomen WA; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Elbersen DM; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., Jacobs EMG; Quality of Life Group, Elkerliek Hospital, P.O. Box 98, 5700, AB, Helmond, The Netherlands., van der Wall E; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, Utrecht, 3508 GA, The Netherlands., Helsper CW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.

المصدر: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2020 Feb; Vol. 14 (1), pp. 9-13. Date of Electronic Publication: 2019 Nov 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE

مواضيع طبية MeSH: Decision Making/*ethics , Neoplasms/*therapy , Referral and Consultation/*standards, Female ; Humans ; Male ; Middle Aged ; Neoplasms/mortality ; Primary Health Care ; Surveys and Questionnaires ; Survivors